Characterization of Parthanatos in Breast Cancer: Implications for Prognosis and PARP Inhibitor Resistance
Parthanatos, a novel form of programmed cell death mediated by PARP1 and driven by DNA damage, has not been comprehensively characterized in breast cancer (BC). Given the widespread clinical use of PARP1 inhibitors for treating BRCA-mutant breast cancers, understanding the role of parthanatos is cru...
Saved in:
Main Authors: | Junjie Tang, Qian Liu, Wei Du, Linxi Chen, Feiyang Qi, Ranxin Zhang, Bang H. Hoang, David S. Geller, Rui Yang, Jichuan Wang, Li Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-05-01
|
Series: | Bioengineering |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-5354/12/6/586 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PJ34 prevents cisplatin-induced hair cell loss via inhibition of PARP-1–AIF parthanatos
by: Huiming Nong, et al.
Published: (2025-06-01) -
Identification and validation of parthanatos-related genes in end-stage renal disease
by: Xuan Dai, et al.
Published: (2025-12-01) -
SCGB3A1‐Epi and KLK10‐Epi Crosstalk With Fibroblasts Promotes Liver Metastasis of Breast Cancer and Pancreatic Ductal Adenocarcinoma
by: Zixue Xuan, et al.
Published: (2025-05-01) -
Molecular Subtyping of Hepatocellular Carcinoma via Lysosome-Related Genes for Prognosis and Therapy Prediction
by: Yao Y, et al.
Published: (2025-07-01) -
Pygo2+ T cells possess immunosuppressive features and inferior immunotherapeutic response in gastric cancer
by: Weilong Chang, et al.
Published: (2025-07-01)